Developer docs
API playgroundTry for free, no card

Search company profiles

Medwave,Inc.

Full company profile

uuid000df5w

Namestring
Medwave,Inc.
Legal namestring
MedWaves, Inc.
Websiteurl
medwaves.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

MedWaves, Inc. is a privately held medical device company founded in 1998 and headquartered in San Diego, California. The company has developed the AveCure Intelligent Therapeutic System, a microwave ablation platform designed to deliver precisely controlled thermal energy for the treatment of soft tissue disease. MedWaves describes itself as the first company to use temperature and frequency-based feedback mechanisms in biomedical microwave energy delivery, with the core technical differentiator being an Intelligent Controller that modulates power pulse train and dynamically selects frequency (902-928 MHz) to adapt to changing tissue characteristics during therapy.

The AveCure platform consists of a capital equipment component (the Intelligent Controller/generator) and a family of single-patient-use accessories including rigid Smart Probes, a Super-Flex Smart Catheter, and a Hybrid Device with four available antenna sizes (1-4 cm active elements). The system operates within an adjustable 60-130°C temperature range, uses a built-in temperature sensor for closed-loop power control, and is designed to be plug-n-play with no cooling, no irrigation, and no return pads required. The platform is FDA 510(k) cleared for soft tissue coagulation/ablation, palliative treatment in spinal procedures via ablation of metastatic malignant lesions, and coagulation/ablation of tissue in bone during surgical procedures.

MedWaves sells directly to healthcare facilities including hospitals, surgical centers, and outpatient clinics, targeting general and oncological surgeons and interventional radiologists who perform soft-tissue tumor ablation procedures percutaneously, laparoscopically, or during open surgery. The revenue model combines one-time capital equipment sales with recurring single-patient-use consumables, and the company reports over 10,000 successful cases worldwide. Headcount is reported at 1-10 employees, no funding rounds or institutional investors are disclosed, and there is no information on named customer accounts, revenue, or leadership team beyond general contact emails.

Short descriptiontext

MedWaves, Inc. is a San Diego-based private medical device company that develops the FDA-cleared AveCure Intelligent Therapeutic System, a microwave ablation platform for minimally invasive soft tissue treatment, sold to hospitals and interventional clinicians via capital equipment plus single-use consumables.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microwave ablation systems, soft tissue ablation, interventional oncology devices, surgical oncology equipment, medical device manufacturing
Industry3 codes
PRIMARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAN
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Interventional Oncology Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1AveCure Intelligent Controller (Generator)
TypeHardware Sales
Description

Sale of the intelligent microwave generator/controller system - a capital equipment purchase for healthcare facilities.

medwaves.com
2Single-Patient-Use Smart Catheters and Probes
TypeHardware Sales
Description

Recurring consumable revenue from single-patient-use antennas, probes, and catheters used during ablation procedures. The company offers AveCure Smart Probe and AveCure Super-Flex Smart Catheter products.

medwaves.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1AveCure
Description

AveCure Intelligent Therapeutic System - microwave ablation system consisting of an intelligent controller and single patient use Smart catheters and probes for soft tissue disease treatment.

medwaves.com
Core offering1 text field

MedWaves designs and manufactures the AveCure Intelligent Therapeutic System, a microwave ablation platform that uses temperature and frequency-based feedback mechanisms to precisely and safely deliver microwave energy for coagulation and ablation of soft tissue. The offering comprises a capital intelligent controller/generator and single-patient-use smart catheters and probes (rigid probes, flexible catheters, and hybrid devices) used in percutaneous, laparoscopic, and intraoperative procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 10,000 successful cases worldwide
+1 more record
Product overview1 text field

MedWaves offers the AveCure Intelligent Therapeutic System, a unified microwave ablation platform for soft tissue treatment. The system consists of an intelligent controller (generator) and an array of single-patient-use Smart catheters and probes (including rigid probes, flexible catheters, and hybrid devices). The platform is designed for percutaneous, laparoscopic, and intraoperative procedures, and can be used standalone or in conjunction with surgery, chemotherapy, and radiation therapy.

Product and service4 records
1AveCure Intelligent Controller
CategoryCapital Equipment / Microwave Ablation Generator
Description

The intelligent generator/controller that powers the AveCure microwave ablation system. It modulates power pulse train to control temperature and energy delivery, adapts dynamically to tissue changes during therapy, and provides adjustable temperature settings (60-130°C). Sold to hospitals, surgical centers, and outpatient facilities for use by surgeons and interventional radiologists.

2AveCure Smart Probe
CategorySingle-Patient-Use Consumable / Ablation Probe
Description

A rigid single-patient-use probe for the AveCure system with plug-n-play design, no cooling requirement, four antenna sizes (1, 2, 3, and 4 cm active elements) for matching treatment volume to lesion size, built-in temperature sensor for power control, and depth markers for precise positioning. Used by surgeons and interventional radiologists for soft tissue ablation procedures.

3AveCure Super-Flex Smart Catheter
CategorySingle-Patient-Use Consumable / Ablation Catheter
Description

A flexible single-patient-use catheter for minimally invasive AveCure procedures. Features a plug-n-play design with a wide range of shaft lengths and flexibility options, and a built-in temperature sensor that enables power control with temperature feedback. Designed for interventional radiologists and surgeons performing minimally invasive soft tissue ablation.

4AveCure Hybrid Device
CategorySingle-Patient-Use Consumable / Hybrid Ablation Device
Description

A combination device with a rigid shaft and flexible body that offers the benefits of both rigid and flexible probe designs for various clinical applications within the AveCure platform. Used by surgeons and interventional radiologists for soft tissue ablation.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Markets the Emprint microwave ablation system, the dominant commercial competitor to MedWaves' AveCure in percutaneous and intraoperative tumor ablation. Both target interventional radiologists and surgeons with a generator-plus-consumable model.

TypeDirect peer
Description

Offers the Microwave Ablation System (formerly Covidien) directly competing with AveCure in soft-tissue tumor ablation. Operates the same capital-plus-single-use-probe commercial model targeting the same clinical specialties.

TypeDirect peer
Description

Markets the Solero Microwave Ablation System, a direct functional competitor in image-guided percutaneous tumor ablation. Targets the same interventional radiology customer base with overlapping soft-tissue ablation indications.

TypeDirect peer
Description

Through its Neuwave acquisition, Ethicon offers a microwave ablation platform competing with MedWaves in soft-tissue tumor treatment. Leverages J&J's scale, GPO contracts, and global distribution to penetrate the same hospital accounts.

5Terumo
TypeDirect peer
Description

Markets microwave and RF ablation systems under its interventional oncology portfolio, directly overlapping MedWaves' tumor ablation use cases. Competes for the same interventional radiology and oncology surgery customers globally.

TypeBroad incumbent
Description

A broad oncology medical device incumbent offering radiation, interventional, and ablation technologies. Competes in the same hospital oncology ecosystem as MedWaves, though Varian is not focused on microwave ablation specifically.

TypeEmerging player
Description

An emerging energy-based surgical device company with advanced energy platforms (Speedboat, MicroBlate) for GI and oncology applications. Comparable in scale and energy-device innovation strategy to MedWaves.

TypeEmerging player
Description

Markets high-intensity focused ultrasound (HIFU) ablation systems, a non-invasive alternative to microwave ablation for soft-tissue tumors. Competes for the same patient population and interventional oncology budgets.

TypeEmerging player
Description

Focused ultrasound ablation developer targeting prostate and soft-tissue indications, an emerging competitor in the minimally invasive ablation space alongside MedWaves. Comparable size and emerging-company profile.

TypeBroad incumbent
Description

Broad neurosurgical and surgical device incumbent with adjacent energy-based and ablation-adjacent offerings. Competes in overlapping surgical hospital channels and provides a strategic-acquisition reference point for MedWaves.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medwave,Inc.

Interventional Oncology Devicesmedwaves.com

MedWaves, Inc. is a San Diego-based private medical device company that develops the FDA-cleared AveCure Intelligent Therapeutic System, a microwave ablation platform for minimally invasive soft tissue treatment, sold to hospitals and interventional clinicians via capital equipment plus single-use consumables.

What Medwave,Inc. does

MedWaves, Inc. is a privately held medical device company founded in 1998 and headquartered in San Diego, California. The company has developed the AveCure Intelligent Therapeutic System, a microwave ablation platform designed to deliver precisely controlled thermal energy for the treatment of soft tissue disease. MedWaves describes itself as the first company to use temperature and frequency-based feedback mechanisms in biomedical microwave energy delivery, with the core technical differentiator being an Intelligent Controller that modulates power pulse train and dynamically selects frequency (902-928 MHz) to adapt to changing tissue characteristics during therapy.

The AveCure platform consists of a capital equipment component (the Intelligent Controller/generator) and a family of single-patient-use accessories including rigid Smart Probes, a Super-Flex Smart Catheter, and a Hybrid Device with four available antenna sizes (1-4 cm active elements). The system operates within an adjustable 60-130°C temperature range, uses a built-in temperature sensor for closed-loop power control, and is designed to be plug-n-play with no cooling, no irrigation, and no return pads required. The platform is FDA 510(k) cleared for soft tissue coagulation/ablation, palliative treatment in spinal procedures via ablation of metastatic malignant lesions, and coagulation/ablation of tissue in bone during surgical procedures.

MedWaves sells directly to healthcare facilities including hospitals, surgical centers, and outpatient clinics, targeting general and oncological surgeons and interventional radiologists who perform soft-tissue tumor ablation procedures percutaneously, laparoscopically, or during open surgery. The revenue model combines one-time capital equipment sales with recurring single-patient-use consumables, and the company reports over 10,000 successful cases worldwide. Headcount is reported at 1-10 employees, no funding rounds or institutional investors are disclosed, and there is no information on named customer accounts, revenue, or leadership team beyond general contact emails.

Medwave,Inc. firmographics

Firmographics
Name
Medwave,Inc.
Legal name
MedWaves, Inc.
Website
https://medwaves.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
MedWaves, Inc. is a San Diego-based private medical device company that develops the FDA-cleared AveCure Intelligent Therapeutic System, a microwave ablation platform for minimally invasive soft tissue treatment, sold to hospitals and interventional clinicians via capital equipment plus single-use consumables.
Ownership category
akta.pro rank

Medwave,Inc. industry classification

Industry
Product category
Interventional Oncology Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAN
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Microwave ablation systems
  • Soft tissue ablation
  • Interventional oncology devices
  • Surgical oncology equipment
  • Medical device manufacturing

Where Medwave,Inc. is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Medwave,Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. AveCure Intelligent Controller (Generator): Sale of the intelligent microwave generator/controller system - a capital equipment purchase for healthcare facilities.
  2. Single-Patient-Use Smart Catheters and Probes: Recurring consumable revenue from single-patient-use antennas, probes, and catheters used during ablation procedures. The company offers AveCure Smart Probe and AveCure Super-Flex Smart Catheter products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Medwave,Inc. product offering

Product offering

Core offering

MedWaves designs and manufactures the AveCure Intelligent Therapeutic System, a microwave ablation platform that uses temperature and frequency-based feedback mechanisms to precisely and safely deliver microwave energy for coagulation and ablation of soft tissue. The offering comprises a capital intelligent controller/generator and single-patient-use smart catheters and probes (rigid probes, flexible catheters, and hybrid devices) used in percutaneous, laparoscopic, and intraoperative procedures.

Product overview

MedWaves offers the AveCure Intelligent Therapeutic System, a unified microwave ablation platform for soft tissue treatment. The system consists of an intelligent controller (generator) and an array of single-patient-use Smart catheters and probes (including rigid probes, flexible catheters, and hybrid devices). The platform is designed for percutaneous, laparoscopic, and intraoperative procedures, and can be used standalone or in conjunction with surgery, chemotherapy, and radiation therapy.

Differentiator

Problem solved

Functional benefit

Brands

  • AveCure: AveCure Intelligent Therapeutic System - microwave ablation system consisting of an intelligent controller and single patient use Smart catheters and probes for soft tissue disease treatment.

Products and services

  • AveCure Intelligent Controller The intelligent generator/controller that powers the AveCure microwave ablation system. It modulates power pulse train to control temperature and energy delivery, adapts dynamically to tissue changes during therapy, and provides adjustable temperature settings (60-130°C). Sold to hospitals, surgical centers, and outpatient facilities for use by surgeons and interventional radiologists.
  • AveCure Smart Probe A rigid single-patient-use probe for the AveCure system with plug-n-play design, no cooling requirement, four antenna sizes (1, 2, 3, and 4 cm active elements) for matching treatment volume to lesion size, built-in temperature sensor for power control, and depth markers for precise positioning. Used by surgeons and interventional radiologists for soft tissue ablation procedures.
  • AveCure Super-Flex Smart Catheter A flexible single-patient-use catheter for minimally invasive AveCure procedures. Features a plug-n-play design with a wide range of shaft lengths and flexibility options, and a built-in temperature sensor that enables power control with temperature feedback. Designed for interventional radiologists and surgeons performing minimally invasive soft tissue ablation.
  • AveCure Hybrid Device A combination device with a rigid shaft and flexible body that offers the benefits of both rigid and flexible probe designs for various clinical applications within the AveCure platform. Used by surgeons and interventional radiologists for soft tissue ablation.

Quantifiable outcome

  • Over 10,000 successful cases worldwide
  • +1 more outcomes

Companies that use Medwave,Inc.

Customer profile

Segments4 records

Ideal customer profiles2 records

Medwave,Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Medwave,Inc. partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Medwave,Inc. competitors and assessment

Company assessment

Direct peers

  • Medtronic: Markets the Emprint microwave ablation system, the dominant commercial competitor to MedWaves' AveCure in percutaneous and intraoperative tumor ablation. Both target interventional radiologists and surgeons with a generator-plus-consumable model.
  • Boston Scientific: Offers the Microwave Ablation System (formerly Covidien) directly competing with AveCure in soft-tissue tumor ablation. Operates the same capital-plus-single-use-probe commercial model targeting the same clinical specialties.
  • AngioDynamics: Markets the Solero Microwave Ablation System, a direct functional competitor in image-guided percutaneous tumor ablation. Targets the same interventional radiology customer base with overlapping soft-tissue ablation indications.
  • Ethicon (Johnson & Johnson): Through its Neuwave acquisition, Ethicon offers a microwave ablation platform competing with MedWaves in soft-tissue tumor treatment. Leverages J&J's scale, GPO contracts, and global distribution to penetrate the same hospital accounts.
  • Terumo: Markets microwave and RF ablation systems under its interventional oncology portfolio, directly overlapping MedWaves' tumor ablation use cases. Competes for the same interventional radiology and oncology surgery customers globally.

Broad incumbents

  • Varian (Siemens Healthineers): A broad oncology medical device incumbent offering radiation, interventional, and ablation technologies. Competes in the same hospital oncology ecosystem as MedWaves, though Varian is not focused on microwave ablation specifically.
  • Integra LifeSciences: Broad neurosurgical and surgical device incumbent with adjacent energy-based and ablation-adjacent offerings. Competes in overlapping surgical hospital channels and provides a strategic-acquisition reference point for MedWaves.

Emerging players

  • Creo Medical: An emerging energy-based surgical device company with advanced energy platforms (Speedboat, MicroBlate) for GI and oncology applications. Comparable in scale and energy-device innovation strategy to MedWaves.
  • EDAP TMS: Markets high-intensity focused ultrasound (HIFU) ablation systems, a non-invasive alternative to microwave ablation for soft-tissue tumors. Competes for the same patient population and interventional oncology budgets.
  • SonaCare Medical: Focused ultrasound ablation developer targeting prostate and soft-tissue indications, an emerging competitor in the minimally invasive ablation space alongside MedWaves. Comparable size and emerging-company profile.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Medwave,Inc. social profiles

Digital presence

Medwave,Inc. compliance and trust

Trust signal

Compliance1 record

Medwave,Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medwave,Inc. leadership team

Management profile

Number of profiles

Medwave,Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medwave,Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medwave,Inc.

What does Medwave,Inc. do?

MedWaves designs and manufactures the AveCure Intelligent Therapeutic System, a microwave ablation platform that uses temperature and frequency-based feedback mechanisms to precisely and safely deliver microwave energy for coagulation and ablation of soft tissue. The offering comprises a capital intelligent controller/generator and single-patient-use smart catheters and probes (rigid probes, flexible catheters, and hybrid devices) used in percutaneous, laparoscopic, and intraoperative procedures.

Is Medwave,Inc. a public or private company?

Medwave,Inc. is a private company. It is classified as unknown and is currently operating.

When was Medwave,Inc. founded?

Medwave,Inc. was founded in 1998. It employs 1 to 10 people.

Where is Medwave,Inc. based?

Medwave,Inc. is headquartered in San Diego, United States, in the North America region.

How does Medwave,Inc. make money?

Two revenue lines are on record. AveCure Intelligent Controller (Generator) is the primary driver. The others are single-Patient-Use Smart Catheters and Probes.

Who are Medwave,Inc.'s main competitors?

Direct peers on record are Medtronic, Boston Scientific, AngioDynamics, Ethicon (Johnson & Johnson) and Terumo. Broad incumbents are Varian (Siemens Healthineers) and Integra LifeSciences. Emerging players are Creo Medical, EDAP TMS and SonaCare Medical.

Does Medwave,Inc. have an API?

No public API is recorded for Medwave,Inc..

What industry is Medwave,Inc. in?

Medwave,Inc.'s product category is Interventional Oncology Devices. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals